Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about IVBIY Recent news which mentions IVBIY FDA Rejects Lilly's Sintilimab/Chemo Combo Therapy In First-Line Lung Cancer Setting March 24, 2022 Tickers IVBIY IVBXF LLY Tags IVBXF Market News News From Benzinga FDA AdComm Votes Against Lilly's Lung Cancer Drug, Sintilimab February 11, 2022 Tickers IVBIY IVBXF LLY Tags Briefs Benzinga Biotech From Benzinga Innovent Biologics, UNION therapeutics Ink Licensing Pact For Inflammatory Dermatology Candidate September 28, 2021 Tickers IVBIY IVBXF Tags News Briefs IVBIY From Benzinga Innovent Biologics, Bolt Join Forces To Develop Anti-Cancer Candidates August 27, 2021 Tickers BOLT IVBIY IVBXF Tags Briefs oncology BOLT From Benzinga Innovent's Sintilimab/Chemo Regime Shows Overall Survival Benefit In Gastric Cancer August 16, 2021 Tickers IVBIY IVBXF LLY Tags General IVBXF Market News From Benzinga Innovent - Eli Lilly's Sintilimab Combo Shows Sustained Survival Benefit In Lung Cancer Patients August 06, 2021 Tickers IVBIY IVBXF LLY Tags General Non/Small Cell Lung Cancer Briefs From Benzinga Innovent Biologics - Incyte's Pemigatinib Application Under Review In China For Bile Duct Cancer July 09, 2021 Tickers INCY IVBIY IVBXF Tags Market News IVBXF FDA From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
